The proteomic profile of a mouse model of proliferative vitreoretinopathy

Proliferative vitreoretinopathy (PVR) develops as a complication of retinal detachment surgery and represents a devastating condition leading to serious vision loss. A good animal model that permits extensive functional studies and drug testing is crucial in finding better therapeutic modalities for...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Márkus Bernadett
Pató Zsuzsanna
Sarang Zsolt
Albert Réka
Tőzsér József
Petrovski Goran
Csősz Éva
Dokumentumtípus: Cikk
Megjelent: Elsevier 2017
Sorozat:FEBS OPEN BIO 7 No. 8
doi:10.1002/2211-5463.12252

mtmt:3255497
Online Access:http://publicatio.bibl.u-szeged.hu/12222
LEADER 01846nab a2200277 i 4500
001 publ12222
005 20200310112122.0
008 171104s2017 hu o 0|| zxx d
022 |a 2211-5463 
024 7 |a 10.1002/2211-5463.12252  |2 doi 
024 7 |a 3255497  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Márkus Bernadett 
245 1 4 |a The proteomic profile of a mouse model of proliferative vitreoretinopathy  |h [elektronikus dokumentum] /  |c  Márkus Bernadett 
260 |a Elsevier  |c 2017 
300 |a 1166-1177 
490 0 |a FEBS OPEN BIO  |v 7 No. 8 
520 3 |a Proliferative vitreoretinopathy (PVR) develops as a complication of retinal detachment surgery and represents a devastating condition leading to serious vision loss. A good animal model that permits extensive functional studies and drug testing is crucial in finding better therapeutic modalities for PVR. A previously established mouse model, using dispase injection, was analyzed from the proteomic point of view, examining global protein profile changes by 2D electrophoresis, image analysis and HPLC-tandem mass spectrometry-based protein identification. The easy applicability of the mouse model was used to study the role of transglutaminase 2 (TG2) in PVR formation by proteomic examination of dispase-induced TG2 knockout vitreous samples. Our data demonstrate that, despite the altered appearance of crystallin proteins, the lack of TG2 did not prevent the development of PVR. 
700 0 1 |a Pató Zsuzsanna  |e aut 
700 0 1 |a Sarang Zsolt  |e aut 
700 0 1 |a Albert Réka  |e aut 
700 0 1 |a Tőzsér József  |e aut 
700 0 1 |a Petrovski Goran  |e aut 
700 0 1 |a Csősz Éva  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/12222/1/The_proteomic_prole_of_a_mouse_model_of_proliferative_vitreoretinopathy__u.pdf  |z Dokumentum-elérés